Trials / Unknown

UnknownNCT03001635

Role of Oxytocin in Myocardial Infarction

The Impact of Oxytocin Administration on Short and Long Term Prognosis in Patients Undergoing ST Elevation Myocardial Infarction

Status: Unknown
Phase: Phase 2 / Phase 3
Study type: Interventional
Enrollment: 52 (estimated)

Sponsor: Sheba Medical Center · Other Government
Sex: All
Age: 18 Years
Healthy volunteers: Accepted

Summary

60 patients admitted to this ICCU at the Sheba medical Center will be randomly divided in to 2 groups. one group will receive the conventional treatment while the second group will receive the conventional treatment plus oxytocin infusion for 48 hours. all participants will undergo echo and cMRI during hospitalization.

Conditions

Myocardial Infarction

Interventions

Type	Name	Description
DRUG	Oxytocin	26 patients will receive Oxytocin infusion for 6h while 26 will receive placebo. all other treatments will be the same and up to date with the current guidelines.
DRUG	Placebos	26 patients will receive 0.9% normal saline infusion for 6h as placebo

Timeline

Start date: 2017-01-01
Primary completion: 2018-12-01
First posted: 2016-12-23
Last updated: 2016-12-23

Source: ClinicalTrials.gov record NCT03001635. Inclusion in this directory is not an endorsement.